BACKGROUND:
The efficacy of hyperbaric oxygen therapy (HBOT) to facilitate wound healing in diabetic lower extremity ulcers is well established. 1 The exact mechanism of HBOTmediated wound healing is unclear, but is thought to relate to increased reactive oxygen species and reactive nitrogen species (ROS &RNS) 2 . ROS and RNS lead to many downstream effects that impact wound healing including increased growth factors, diminished inflammatory responses and improved neovascularization. The impact on tissue perfusion, however, is not known. The purpose of this pilot study was to ascertain the effects of HBOT on the microvasculature of chronic wounds as assessed by fluorescent angiography as compared with healthy controls.
METHODS:
Patients underwent fluorescent angiography at 4 different time points: immediately prior and immediately after the first and second HBOT treatments. Photo imaging with infrared camera began concurrently with the initiation of the IC-Green™ injection and lasted for 5 minutes. All videos were analyzed via MATLAB. The wound bed and the peri-wound area were then outlined as masks for the image analysis. 2 time points were determined: the onset of inflow and the time of maximal outflow (defined as the surrogate for onset of venous outflow).
RESULTS:
Immediately after HBOT, there was evidence of increased flow. The onset of arterial inflow as well as venous outflow occurred earlier after the initial HBO treatment when compared with pretreatment in the chronic wound patients, indicating an immediate HBO associated vasodilitory effect. Interestingly, in healthy controls, the opposite phenomenon was observed in that both arterial and venous flow occurred in a delayed manner as a result of HBOT, perhaps suggesting a vasoconstrictive effect, consistent with prior reports. 
CONCLUSION:
This pilot study demonstrates that hyperbaric oxygen therapy appears to immediately impact the microcirculation both on an inflow (arterial) and outflow (venous) level. Interestingly, results of this study suggest inherent differences in micro-vascular physiologic responsiveness between healthy and chronic wound patients. This work offers an insight into the potential mechanism of HBOT and may direct future applications and eventually customize care.
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INTRODUCTION:
Skeletal muscle loss can result from trauma or oncologic resection, leading to severe cosmetic and functional deficits. Muscle derived stem cells (MDSCs) can be isolated by using a serial preplating technique and have inherent myogenic potential. 1 Since their identification, previous research on MDSCs has mostly focused on ex-vivo gene therapy applications aimed at treating muscular dystrophy, and little is known about the optimal population for skeletal muscle tissue engineering. 2, 3 The aim of this study is to determine which preplate population is better suited for muscle regeneration and optimize the in vitro conditions for creating an implantable skeletal muscle construct.
MATERAIAL AND METHODS:
Murine MDSCs were isolated from transgenic B6 mice expressing red fluorescent protein (RFP) under a ubiquitin C promoter. Proliferation studies of various preplate populations were performed by utilizing bright-field microscopy to determine time to confluence. Myogenic potential was assessed by immunostaining for myosin-heavy chain (MyHC) to evaluate myotube formation. In vitro skeletal muscle constructs were created using various concentrations of RFP-expressing MDSCs (5x10 5 , 1x10 6 , 2x10 6 cells/construct) seeded onto decellularized muscle scaffolds, and cellular viability and scaffold repopulation were assessed using confocal microscopy. After 14 days in culture, constructs were further analyzed by histology and immunofluorescence.
RESULTS:
Preplates 3, 4 and 5 demonstrated faster expansion rates from time of isolation compared to prelates 1, 2 and 6 (p<0.05). In terms of their myogenic potential, preplates 3, 4, and 5 had comparable fusion indices (2.53 ± 0.51, 3.22 ± 0.80, 3.10 ± 1.46, p=0.316). Confocal imaging of MDSC-seeded construct demonstrated cellular viability at 48 hours and 14 days with progressive concentric scaffold repopulation at all three cellular concentrations. Immunostaining for MyHC demonstrated myotube formation within the constructs after14 days in culture. Further histologic analysis by H&E stain confirmed successful scaffold repopulation and higher cellular density in the constructs seeded with 2x10 6 cells.
CONCLUSION:
The results of this study indicate that preplates 3, 4 and 5 possess high expansion rates and myogenic potentials. Furthermore, MDSCs are capable of successful repopulation of decellularized muscle scaffolds and myotube formation in a 3-dimensional construct. Future experiments will assess the muscle regeneration capability of the MDSC-enriched scaffolds in vivo.
